Company: LEN
Filing Date: 2025-05-13
Form Type: 424B5
Source: 0001193125-25-118869
Chunk: 59

Company: LENNAR CORP /NEW/
Filing Date: 2025-05-13
Form: 424B5
Chunk 59
---
 and is consistent with and within the limits of, any Similar Law. Fiduciaries of such Plans should consult with their counsel before purchasing any
Notes to determine the suitability of the Notes for such plan and the need for, and the availability, if necessary, of any exemptive relief under any such Similar Laws.

Consultation with Counsel

The foregoing
discussion is general in nature and is not intended to be comprehensive; neither the Company nor the underwriters make any representation that the purchase or holding of such Notes meets the relevant legal requirements with respect to any particular
investor. The complexity of these rules, and the severity of potential

S-36

penalties, make it particularly important that fiduciaries or other persons considering an acquisition of Notes on behalf of or with the plan assets of any Plan consult with its counsel regarding
the suitability of an acquisition of the Notes in light of such prospective purchaser’s particular circumstances.

Deemed Representation

By its acceptance of any Note or any interest in a Note, the purchaser of the Note will be deemed to have represented and warranted that
either:

(1) it is not acquiring or holding such Note or an interest in it with the assets of a Plan; or

(2) the acquisition and holding of such Note by it will not constitute or result in a
non-exempt prohibited transaction under Section 406 of ERISA or Section 4975 of the Code or a violation of any provisions of any applicable Similar Law, and none of the Transaction Parties is its
fiduciary in connection with its investment in such Note pursuant to the offering described in this prospectus supplement.

S-37

UNDERWRITING BofA Securities, Inc., Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, Mizuho Securities USA LLC and Wells Fargo Securities, LLC are acting as joint book-running managers of the offering and as representatives of the underwriters named below. Subject to the terms and conditions stated in an underwriting agreement dated the date of this prospectus supplement, each underwriter named below has severally agreed to purchase, and we have agreed to sell to that underwriter, the principal amount of Notes set forth opposite the underwriter’s name.

| Name                          |     | Principal Amount 
 of Notes         |             |
|:------------------------------|:----|:-----------------|------------:|
| BofA Securities, Inc.         |     | $                |  87,500,000 |
| Goldman Sachs & Co. LLC       |     | $